Search by Drug Name or NDC
NDC 70710-1391-09 Droxidopa 300 mg/1 Details
Droxidopa 300 mg/1
Droxidopa is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals USA Inc.. The primary component is DROXIDOPA.
MedlinePlus Drug Summary
Droxidopa is used to treat symptoms (dizziness, lightheadedness, or a fainting sensation [feeling that you are about to black out]) of neurogenic orthostatic hypotension (a sudden fall in blood pressure that occurs when a person assumes a standing position caused by certain nervous system conditions). Droxidopa is in a class of medications called alpha and beta-adrenergic agonists. It works by increasing the levels of norepinephrine, a natural substance in the body.
Related Packages: 70710-1391-09Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Droxidopa
Product Information
| NDC | 70710-1391 |
|---|---|
| Product ID | 70710-1391_98a2a992-f0a2-47e4-91c0-bdae39b73e63 |
| Associated GPIs | 38700030000150 |
| GCN Sequence Number | 072025 |
| GCN Sequence Number Description | droxidopa CAPSULE 300 MG ORAL |
| HIC3 | J5H |
| HIC3 Description | ADRENERGIC VASOPRESSOR AGENTS |
| GCN | 36093 |
| HICL Sequence Number | 040936 |
| HICL Sequence Number Description | DROXIDOPA |
| Brand/Generic | Generic |
| Proprietary Name | Droxidopa |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Droxidopa |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 300 |
| Active Ingredient Units | mg/1 |
| Substance Name | DROXIDOPA |
| Labeler Name | Zydus Pharmaceuticals USA Inc. |
| Pharmaceutical Class | Catecholamines [CS], Increased Blood Pressure [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA211818 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70710-1391-09 (70710139109)
| NDC Package Code | 70710-1391-9 |
|---|---|
| Billing NDC | 70710139109 |
| Package | 90 CAPSULE in 1 BOTTLE (70710-1391-9) |
| Marketing Start Date | 2021-02-19 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 2.72296 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | DROXIDOPA 300 MG CAPSULE |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis